Design of a Kv1.3×CD25 bispecific antibody to preferentially inhibit activated T cells and ameliorate T-cell-driven colitis

Biophysical Reports · Elsevier

Abstract

Publication date: 10 January 2027 Source: European Journal of Pharmacology, Volume 1040 Author(s): Jia Deng, Yan Liu, Na Chen, Yuhan Zhang, Hui Guo, Jin Zhu, Feng Wang

Read at publisher →

Similar articles